| Nephrocare Health Services Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 544647 |
NSE Symbol : NEPHROPLUS |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE428V01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 96.56 |
Market Cap(₹Cr) : 6,163.76 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 170.38 | 164.33 | 160.66 | 155.92 | 148.83 | 145.01 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 170.38 | 164.33 | 160.66 | 155.92 | 148.83 | 145.01 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.12 | 6.14 | 3.46 | 2.87 | 2.97 | 2.73 |
| Total Income | 176.50 | 170.47 | 164.13 | 158.79 | 151.80 | 147.74 |
| Total Expenditure | 146.24 | 142.26 | 137.80 | 132.45 | 129.08 | 123.26 |
| PBIDT | 30.27 | 28.21 | 26.33 | 26.34 | 22.72 | 24.48 |
| Interest | 0.49 | 1.27 | 3.96 | 41.05 | 3.48 | 3.68 |
| PBDT | 29.78 | 26.94 | 22.37 | -14.71 | 19.24 | 20.80 |
| Depreciation | 13.09 | 15.95 | 13.41 | 15.91 | 12.35 | 13.39 |
| Tax | 6.07 | 3.91 | 3.07 | 4.48 | 2.67 | 2.43 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.94 | -3.80 | -2.56 | -2.68 | -0.78 | -0.68 |
| Reported Profit After Tax | 12.56 | 10.89 | 8.45 | -32.41 | 5.01 | 5.67 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 12.56 | 10.89 | 8.45 | -32.41 | 5.01 | 5.67 |
| EPS (Unit Curr.) | 1.25 | 1.09 | 0.90 | -3.82 | 0.60 | 0.70 |
| EPS (Adj) (Unit Curr.) | 1.25 | 1.09 | 0.90 | -3.82 | 0.60 | 0.70 |
| Calculated EPS (Unit Curr.) | 1.25 | 1.09 | 0.84 | -17.91 | 0.50 | 6.43 |
| Calculated EPS (Adj) (Unit Curr.) | 1.25 | 1.09 | 0.84 | -17.91 | 0.50 | 6.43 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.01 | 4.34 | 3.37 | -71.65 | 2.00 | 25.71 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.01 | 4.34 | 3.37 | -71.65 | 2.00 | 25.71 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 20.07 | 20.07 | 20.07 | 3.62 | 20.07 | 1.77 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.77 | 17.17 | 16.39 | 16.89 | 15.27 | 16.88 |
| PBDTM(%) | 17.48 | 16.39 | 13.92 | -9.43 | 12.93 | 14.34 |
| PATM(%) | 7.37 | 6.63 | 5.26 | -20.79 | 3.37 | 3.91 |
